$艾利科技 (ALGN.US)$sank more than 10% Wednesday after the bell after the medical-device maker trailed analyst estimates for fiscal Q2 revenues and issued fiscal Q3 guidance on the light side of what analysts had been expecting. ALGN fell 11.8% to $215.50 shortly before 5 p.m. ET following release of its quarterly results and forward guidance. The stock eased after Align reported $1.03...
Ann Xagoras 樓主 :